Literature DB >> 23061103

Meetings of the WHO working group on surveillance of influenza antiviral susceptibility – Geneva, November 2011 and June 2012.

.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23061103

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  60 in total

1.  Application of a seven-target pyrosequencing assay to improve the detection of neuraminidase inhibitor-resistant Influenza A(H3N2) viruses.

Authors:  Daisuke Tamura; Margaret Okomo-Adhiambo; Vasiliy P Mishin; Zhu Guo; Xiyan Xu; Julie Villanueva; Alicia M Fry; James Stevens; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

2.  Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y.

Authors:  Andrew J Burnham; Tatiana Baranovich; Bindumadhav M Marathe; Jianling Armstrong; Robert G Webster; Elena A Govorkova
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

3.  Detection of a transient R292K mutation in influenza A/H3N2 viruses shed for several weeks by an immunocompromised patient.

Authors:  N Esther Babady; Jennifer M Laplante; Yi-Wei Tang; Kirsten St George
Journal:  J Clin Microbiol       Date:  2015-01-14       Impact factor: 5.948

4.  Molecular surveillance of antiviral drug resistance of influenza A/H3N2 virus in Singapore, 2009-2013.

Authors:  Hong Kai Lee; Julian Wei-Tze Tang; Tze Ping Loh; Aeron C Hurt; Lynette Lin-Ean Oon; Evelyn Siew-Chuan Koay
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

5.  Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.

Authors:  Henju Marjuki; Vasiliy P Mishin; Anton P Chesnokov; Joyce Jones; Juan A De La Cruz; Katrina Sleeman; Daisuke Tamura; Ha T Nguyen; Ho-Sheng Wu; Feng-Yee Chang; Ming-Tsan Liu; Alicia M Fry; Nancy J Cox; Julie M Villanueva; Charles T Davis; Larisa V Gubareva
Journal:  J Infect Dis       Date:  2014-08-14       Impact factor: 5.226

6.  Antiviral susceptibility of variant influenza A(H3N2)v viruses isolated in the United States from 2011 to 2013.

Authors:  K Sleeman; V P Mishin; Z Guo; R J Garten; A Balish; A M Fry; J Villanueva; J Stevens; L V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2014-01-21       Impact factor: 5.191

7.  Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.

Authors:  Henju Marjuki; Vasiliy P Mishin; Anton P Chesnokov; Juan A De La Cruz; Charles T Davis; Julie M Villanueva; Alicia M Fry; Larisa V Gubareva
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

8.  Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference.

Authors:  Jennifer L McKimm-Breschkin; Shibo Jiang; David S Hui; John H Beigel; Elena A Govorkova; Nelson Lee
Journal:  Antiviral Res       Date:  2017-11-21       Impact factor: 5.970

9.  In Vitro and In Vivo Characterization of Novel Neuraminidase Substitutions in Influenza A(H1N1)pdm09 Virus Identified Using Laninamivir-Mediated In Vitro Selection.

Authors:  Khristine Kaith S Lloren; Jin Jung Kwon; Won-Suk Choi; Ju Hwan Jeong; Su Jeong Ahn; Young Ki Choi; Yun Hee Baek; Min-Suk Song
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 10.  Detection and management of antiviral resistance for influenza viruses.

Authors:  Guy Boivin
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.